Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,886,849
-
Share change
-
+920,639
-
Total reported value
-
$138,909,378
-
Price per share
-
$2.90
-
Number of holders
-
83
-
Value change
-
-$2,667,724
-
Number of buys
-
32
-
Number of sells
-
41
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q1 2022
As of 31 Mar 2022,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,886,849 shares.
The largest 10 holders included
TRV GP IV, LLC, Deep Track Capital, LP, Atlas Venture Life Science Advisors, LLC, GILDER GAGNON HOWE & CO LLC, Alphabet Inc., Casdin Capital, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., TCG Crossover Management, LLC, and JANUS HENDERSON GROUP PLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.